Bradykinin B2 receptor agonism: a novel therapeutic strategy for myocardial infarction?
Duchene
Johan
J
Department of Cardiovascular Research, Max Delbrück Center for Molecular Medicine (MDC), Berlin-Buch, Germany.
Bader
Michael
M
D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D051379:Mice; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D051381:Rats; D043782:Receptor, Bradykinin B2 / Q000819:agonists*; D013318:Stroke Volume / Q000502:physiology; D020257:Ventricular Remodeling / Q000502:physiology
D002316:Cardiotonic Agents; D043782:Receptor, Bradykinin B2